Corcept Therapeutics, Inc. (CORT)
77.49
+4.16
(+5.67%)
USD |
NASDAQ |
Jun 09, 16:00
77.46
-0.03
(-0.04%)
After-Hours: 20:00
Corcept Therapeutics Research and Development Expense (TTM) : 260.44M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abeona Therapeutics, Inc. | 24.41M |
| Merck & Co., Inc. | 21.57B |
| Liquidia Corp. | 44.01M |
| Indivior Pharmaceuticals, Inc. | 67.00M |
| ANI Pharmaceuticals, Inc. | 51.70M |